Chong-Jen Yu Selected Research

Chong-Jen Yu Research Topics

Disease

92	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 02/2002
57	Neoplasms (Cancer) 01/2024 - 02/2002
45	Lung Neoplasms (Lung Cancer) 05/2024 - 01/2005
38	Adenocarcinoma of Lung 03/2023 - 09/2005
26	Chronic Obstructive Pulmonary Disease (COPD) 04/2024 - 03/2007
22	Tuberculosis (Tuberculoses) 01/2024 - 09/2004
16	Infections 07/2023 - 08/2005
15	Pneumonia (Pneumonitis) 11/2020 - 02/2005
14	Adenocarcinoma 01/2024 - 01/2005
13	Sepsis (Septicemia) 01/2022 - 08/2005
12	Neoplasm Metastasis (Metastasis) 01/2024 - 01/2005
11	Disease Progression 01/2023 - 10/2008
9	Critical Illness (Critically Ill) 01/2024 - 02/2005
8	Latent Tuberculosis 12/2022 - 12/2013
7	Lung Diseases (Lung Disease) 01/2024 - 04/2003
7	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 09/2003
7	Brain Neoplasms (Brain Tumor) 01/2022 - 01/2008
6	Respiratory Insufficiency (Respiratory Failure) 11/2023 - 03/2004
6	Septic Shock (Toxic Shock Syndrome) 10/2019 - 12/2012
5	Pulmonary Tuberculosis 11/2023 - 01/2010
5	Emphysema 01/2022 - 09/2014
5	Malignant Pleural Effusion 01/2019 - 06/2012
4	Cross Infection (Nosocomial Infection) 01/2024 - 09/2003
4	Pulmonary Emphysema 01/2018 - 02/2004
3	Pulmonary Hypertension 01/2024 - 04/2015
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2024 - 07/2005
3	Human Influenza (Influenza) 01/2022 - 07/2013
3	Acute Kidney Injury (Acute Renal Failure) 01/2021 - 01/2014
3	Hemorrhage 11/2020 - 09/2006
3	Carcinoma (Carcinomatosis) 08/2020 - 06/2005
3	Lymphopenia (Lymphocytopenia) 01/2019 - 05/2004
3	Inflammation (Inflammations) 01/2019 - 06/2007
3	Pneumothorax 01/2019 - 07/2011
3	Multiple Organ Failure (MODS) 07/2018 - 09/2003
3	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 04/2016 - 04/2013

Drug/Important Bio-Agent (IBA)

67	ErbB Receptors (EGF Receptor)IBA 01/2024 - 02/2006
39	Tyrosine Kinase InhibitorsIBA 01/2024 - 10/2008
28	Gefitinib (Iressa)FDA Link 03/2023 - 06/2005
16	Erlotinib Hydrochloride (CP 358,774)FDA Link 03/2023 - 12/2007
16	Biomarkers (Surrogate Marker)IBA 07/2021 - 06/2008
14	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2005
10	Adrenal Cortex Hormones (Corticosteroids)IBA 09/2023 - 01/2010
10	PlatinumIBA 01/2023 - 06/2012
10	Pemetrexed (MTA)FDA Link 10/2020 - 05/2010
9	osimertinibIBA 01/2024 - 01/2017
9	AfatinibIBA 03/2023 - 02/2015
8	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 07/2015
8	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 09/2003
8	Interferon-gamma (Interferon, gamma)IBA 01/2018 - 11/2006
7	Cisplatin (Platino)FDA LinkGeneric 10/2020 - 04/2007
7	Gemcitabine FDA Link 01/2016 - 05/2008
6	GoldIBA 12/2020 - 01/2016
5	Carboplatin (JM8)FDA LinkGeneric 01/2023 - 07/2013
5	ceritinibIBA 01/2022 - 01/2016
5	Messenger RNA (mRNA)IBA 01/2019 - 02/2002
5	Placenta Growth FactorIBA 01/2018 - 02/2004
5	C-Reactive ProteinIBA 01/2016 - 05/2004
4	SmokeIBA 11/2023 - 08/2010
4	Anaplastic Lymphoma KinaseIBA 01/2023 - 01/2016
4	SteroidsIBA 07/2021 - 01/2017
4	CytokinesIBA 01/2021 - 11/2006
4	Phosphotransferases (Kinase)IBA 01/2021 - 12/2007
4	Budesonide (Pulmicort)FDA LinkGeneric 09/2020 - 01/2016
4	Formoterol Fumarate (Oxis)FDA Link 09/2020 - 01/2016
4	Fluticasone-Salmeterol Drug Combination (Advair)FDA Link 09/2020 - 01/2016
4	FluoroquinolonesIBA 09/2017 - 06/2009
4	Moxifloxacin (Avelox)FDA Link 09/2017 - 06/2009
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2016 - 02/2002
4	Triggering Receptor Expressed on Myeloid Cells-1IBA 01/2016 - 11/2010
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 05/2008
3	NivolumabIBA 01/2023 - 01/2018
3	Indicators and Reagents (Reagents)IBA 01/2023 - 10/2012
3	Bevacizumab (Avastin)FDA Link 01/2023 - 08/2012
3	Matrix Metalloproteinases (MMPs)IBA 12/2022 - 08/2009
3	CreatinineIBA 03/2022 - 01/2014
3	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2013
3	Alanine Transaminase (SGPT)IBA 03/2021 - 06/2009
3	Interleukin-8 (Interleukin 8)IBA 11/2020 - 02/2002
3	EnzymesIBA 07/2020 - 10/2011
3	B7-H1 AntigenIBA 01/2020 - 01/2017
3	CrizotinibIBA 01/2020 - 11/2014
3	LipidsIBA 01/2019 - 08/2005
3	Angiotensin Receptor AntagonistsIBA 01/2019 - 01/2014
3	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2018 - 09/2014
3	Thymidylate SynthaseIBA 09/2017 - 10/2011
3	A-factor (Streptomyces)IBA 11/2016 - 03/2014
3	ProcalcitoninIBA 01/2016 - 05/2011
3	Interleukin-10 (Interleukin 10)IBA 06/2015 - 11/2006
3	Rifampin (Rifampicin)FDA LinkGeneric 03/2014 - 09/2004

Therapy/Procedure

58	Therapeutics 01/2024 - 04/2003
34	Drug Therapy (Chemotherapy) 01/2024 - 12/2002
15	Artificial Respiration (Mechanical Ventilation) 01/2024 - 04/2003
8	Radiotherapy 01/2022 - 01/2008
7	Critical Care (Surgical Intensive Care) 11/2020 - 09/2006
6	Mechanical Ventilators (Ventilator) 01/2024 - 01/2002
5	Length of Stay 11/2020 - 02/2005
4	Aftercare (After-Treatment) 01/2021 - 01/2008
3	Renal Dialysis (Hemodialysis) 07/2023 - 06/2011
3	Immunotherapy 12/2021 - 01/2018
3	Chest Tubes (Chest Tube) 04/2018 - 08/2010